Form D
View Original Filing
Notice of Exempt Offering of Securities
Item 1. Issuer's Identity
Name of Issuer:
NEWLINK GENETICS CORP
Jurisdiction of Incorporation/Organization
DE
Year of Incorporation/Organization
Over Five Years Ago
Item 2 Issuer Principal Place of Business and Contact Information
2901 SOUTH LOOP DRIVE
BUILDING 3, SUITE 3900
AMES, IA 50010
Phone Number:
subscription required
Item 3. Related Persons
Name
CHARLES LINK, M.D.
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
NICHOLAS VAHANIAN, M.D.
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
GORDON H. LINK
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
TOM RAFFIN, M.D.
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
ERNEST TALARICO, III
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
DAVID J. LUNDQUIST
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
SARAH J. ALEXANDER, M.D.
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
KENNETH LYNN
Address
subscription required
Relationship(s)
Clarification of Response
Item 4. Industry Group
BIOTECHNOLOGY
Item 5. Issuer Size
Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
DECLINE TO DISCLOSE
Item 6. Federal Exemptions and Exclusions Claimed
Item 7. Type of Filing
New Notice
Date of First Sale in this Offering:
07/17/2009
Item 8. Duration of Offering
Does the issuer intend this offering to last more than one year?
No
Item 9. Type(s) of Securities Offered
Item 10. Business Combination Transaction
Is this offering being made in connection with a business combination
transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response
Item 11. Minimum Investment
Minimum Investment accepted from any outside investor
2500000
Item 13. Offering and Sales Amounts
Total Offering Amount
7500000
Total Amount Sold
7500000
Total Remaining to be Sold
0
Clarification of Response
NEW OFFERING OF SERIES D PREFERRED
Item 14. Investors
Securities in the offering have been or may be sold to persons
who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
1
Item 15. Sales Commissions and Finders' Fees Expenses
Sales Commissions:
0.0
Finders' Fees
0.0
Clarification of Response
Item 16. Use of Proceeds
Provide the amount of the gross proceeds of the offering
that has been or is proposed to be used for payments to any of the persons required
to be named as executive officers,directors or promoters in response to Item 3 above.
0.0
Clarification of Response
Signature and Submission
Issuer Name
NEWLINK GENETICS CORP
Issuer Signature
/GORDON LINK/
Signer Name
GORDON LINK
Signer Title
CFO
Signature Date
07/28/2009